Style | Citing Format |
---|---|
MLA | Yoo SGK, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart, vol. 19, no. 1, 2024, pp. 44-. |
APA | Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, Houehanou C, Norov B, Karki KB, Azangoukhyavy M, Marcus ME, Aryal KK, Brant LCC, Theilmann M, Cifkova R, Lunet N, Gurung MS, Mwangi JK, ... Flood D (2024). Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart, 19(1), 44-. |
Chicago | Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, Rohloff P, et al.. "Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data." Global heart 19, no. 1 (2024): 44-. |
Harvard | Yoo SGK et al. (2024) 'Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data', Global heart, 19(1), pp. 44-. |
Vancouver | Yoo SGK, Chung GS, Bahendeka SK, Sibai AM, Damasceno A, Farzadfar F, et al.. Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data. Global heart. 2024;19(1):44-. |
BibTex | @article{ author = {Yoo SGK and Chung GS and Bahendeka SK and Sibai AM and Damasceno A and Farzadfar F and Rohloff P and Houehanou C and Norov B and Karki KB and Azangoukhyavy M and Marcus ME and Aryal KK and Brant LCC and Theilmann M and Cifkova R and Lunet N and Gurung MS and Mwangi JK and Martins J and Haghshenas R and Sturua L and Vollmer S and Barnighausen T and Atun R and Sussman JB and Singh K and Moghaddam SS and Guwatudde D and Geldsetzer P and Mannegoehler J and Huffman MD and Davies JI and Flood D}, title = {Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data}, journal = {Global heart}, volume = {19}, number = {1}, pages = {44-}, year = {2024} } |
RIS | TY - JOUR AU - Yoo SGK AU - Chung GS AU - Bahendeka SK AU - Sibai AM AU - Damasceno A AU - Farzadfar F AU - Rohloff P AU - Houehanou C AU - Norov B AU - Karki KB AU - Azangoukhyavy M AU - Marcus ME AU - Aryal KK AU - Brant LCC AU - Theilmann M AU - Cifkova R AU - Lunet N AU - Gurung MS AU - Mwangi JK AU - Martins J AU - Haghshenas R AU - Sturua L AU - Vollmer S AU - Barnighausen T AU - Atun R AU - Sussman JB AU - Singh K AU - Moghaddam SS AU - Guwatudde D AU - Geldsetzer P AU - Mannegoehler J AU - Huffman MD AU - Davies JI AU - Flood D TI - Global Prevalence of Aspirin Use for Primary Prevention of Cardiovascular Disease: A Cross-Sectional Study of Nationally Representative, Individual-Level Data JO - Global heart VL - 19 IS - 1 SP - 44 EP - PY - 2024 ER - |